Cytel EU JCA Taskforce

Established in 2023, the Cytel EU JCA Taskforce brings together a multidisciplinary team of statisticians, market access strategists, and local experts to address the evolving EU JCA landscape. The Taskforce actively tracks EU JCA announcements, delivers comprehensive staff training, and examines the complex methodological interdependencies between EU Joint Clinical Assessments and local market access requirements. Through a wide range of dissemination activities — including webinars, blogs, conference presentations, and influential peer-reviewed publications — the team plays a key role in advancing both understanding and strategic adaptation across stakeholders.

Related Articles

Inside the Black Box: Making Sense of the Individualised Treatment Comparator for JCA
Blog
June 4, 2026
Inside the Black Box: Making Sense of the Individualised Treatment Comparator for JCA
Read More